Temporary pact reached on funding South Korean workers at U.S. bases who were put on unpaid leave this year via idreesali114
FILE PHOTO: The Pentagon logo is seen behind the podium in the briefing room at the Pentagon in Arlington, Virginia, U.S., January 8, 2020. REUTERS/Al Drago
“This decision enables a more equitable sharing of the employee labor burden by the ROK and the U.S.,” the Pentagon said, referring to South Korea by the initials of its official name, the Republic of Korea. The ministry said South Korea would work with the United States to reach an agreement “as soon as possible” on the broader cost-sharing arrangement, which remains in dispute after it lapsed at the end of last year, leading to the workers being furloughed in the first place.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Armed with disinfectant and admonishments, South Korean robot fights coronavirus spreadA self-driving robot equipped with cameras and an LED screen greets visitors at the lobby in the headquarters of South Korea's largest mobile operator, checking their temperature, dispensing hand sanitiser and disinfecting the floor.
Read more »
Korean Gaming Giant Nexon To Spend $1.5 Billion On Global Entertainment CompaniesThe investment is “a good use of Nexon’s cash in a market defined by low interest rates,” Owen Mahoney, the chief executive officer of Nexon, said in a statement. Nexon said it held 518 billion yen ($4.8 billion) in cash as of March 31.
Read more »
US and South Korea reach agreement to fund Koreans working for US Forces KoreaThe Pentagon has announced that the Department of Defense and South Korea have reached a new cost-sharing agreement for the country to fund over 4,000 Korean nationals who work for US Forces Korea through the end of 2020
Read more »
South Korea's Celltrion aims to start in-human COVID-19 drug trial in JulySouth Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.
Read more »